
Qualitative and Quantitative Estimation of Hydroquinone in Skin Whitening Cosmetics
228
nisms Regulating Skin Pigmentation: The Rise and Fall
of Complexion Coloration,” International Journal of
Molecular Sciences, Vol. 10, No. 9, 2009, pp. 4066-4087.
doi:10.3390/ijms10094066
[8] J. Lee, K. Jung, Y. S. Kim and D. Park, “Diosgenin Inhi-
bits Melanogenesis through the Activation of Phospha-
tidylinositol-3-Kinase Pathway (PI3K) Signaling,” Life
Sciences, Vol. 81, No. 3, 2007, pp. 249-254.
doi:10.1016/j.lfs.2007.05.009
[9] T. S. Chang, “An Updated Review of Tyrosinase Inhibi-
tors,” International Journal of Molecular Sciences, Vol.
10, No. 6, 2009, pp. 2440-2475.
doi:10.3390/ijms10062440
[10] M. Mastore, L. Kohler and A. J. Nappi, “Production and
Utilization of Hydrogen Peroxide Associated with Mela-
nogenesis and Tyrosinase-Mediated Oxidations of DOPA
and Dopamine,” FEBS Journal, Vol. 272, No. 10, 2005,
pp. 2407-2415. doi:10.1111/j.1742-4658.2005.04661.x
[11] N. Smit, J. Vicanova and S. Pavel, “The Hunt for Natural
Skin Whitening Agents,” International Journal of Mo-
lecular Sciences, Vol. 10, No. 12, 2009, pp. 5326-5349.
doi:10.3390/ijms10125326
[12] R. Halaban, R. S. Patton, E. Cheng, S. Svedine, E. S. Trom-
betta, M. L. Wahl, S. Ariyan and D. N. Hebert, “Abnor-
mal Acidification of Melanoma Cells Induces Tyrosinase
Retention in the Early Secretory Pathway,” The Journal
of Biological Chemistry, Vol. 277, No. 17, 2002, pp.
14821-14828.
[13] S. H. Hamed, P. Sriwiiyanont, R. R. Wickett and R.
Boissy, “Effect of Deoxyarbutin on Melanogenesis: In
Vivo Comparison with Other Melanogenesis Inhibitor,”
Journal of Cosmetic Science, Vol. 55, No. 1, 2004, pp.
118-119.
[14] S. B. Adebajo, “An Epidermiological Survey of the Use
of Cosmetic Skin Lightening Cosmetics among Traders in
Lagos, Nigeria,” West African Journal of Medicine, Vol.
21, No. 1, 2002, pp. 51-55.
[15] N. Hardwick, et al., “Exogenous Ochronosis: An Epider-
miological Study,” British Journal of Dermatology, Vol.
120, No. 2, 1989, pp. 229-238.
doi:10.1111/j.1365-2133.1989.tb07787.x
[16] Twenty Fourth Directive 2000/6/EG Publication nr L056.
European Union, 2000.
[17] Food and Drug Administration, “Skin Bleaching Drug
Products for Over-the-Counter Human Use; Proposed
Rule,” US Department of Health and Human Services, 29
August 2006.
[18] Federal Register, “Proposed Rules,” Vol. 71, No. 167,
2006, pp. 51146-51155.
[19] E. Stahal, “Thin Layer Chromatography,” George Allen
and Unwin Limited, London, 1969.
[20] M. W. Akhtar, N. Kausar, M. N. Nawazish and Z. Hus-
sain,” Pakistan Journal of Biological Sciences, Vol. 16,
No. 2, 1981, p. 71.
[21] V. M. Veralla Rowell, V. Verallo, K. Graupe, L. Lopez-
Villafuerte and M. Garcia-Lopez, “Double-Blind Com-
parison of Azelaic Acid and Hydroquinone in the Treat-
ment of Melasma,” Acta Dermato-Venereological Sup-
plementum (Stocckh), Vol. 143, 1981, pp. 58-61.
[22] K. B. Penny, C. J. Smith and J. C. Allen, “Depigmenting
Action of Hydroquinone Depends on Disruption of Fun-
damental Cell Processes,” Journal of Investigative Der-
matology, Vol. 82, 1984, pp. 308-310.
doi:10.1111/1523-1747.ep12260588
[23] H. Jiang and T. Yan, “Determination of Hydroquinone in
Cosmetics by GC-MS,” Weishing Yanjiu, Vol. 30, No. 1,
2001, p. 22.
[24] L. Cheng-Hui, et al., “Determination of Hydroquinone in
Cosmetic Emulsion Using Microdialysis Sampling Cou-
pled with HPLC,” Journal of Pharmaceutical & Bio-
medical Analysis, Vol. 38, No. 3, 2005, pp. 414-419.
Copyright © 2012 SciRes. JCDSA